Amir Nutman

Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial

Mical Paul, George L. Daikos, Emanuele Durante‐Mangoni et al. · The Lancet Infectious Diseases · 2018 · 593 citations

Severe Infections, Health Sciences, Antibiotics +9

Treatment Outcomes of Colistin- and Carbapenem-resistant Acinetobacter baumannii Infections: An Exploratory Subgroup Analysis of a Randomized Clinical Trial

Yaakov Dickstein, Jonathan Lellouche, Maayan Ben Dalak Amar et al. · Clinical Infectious Diseases · 2018 · 119 citations

Eplerenone for chronic central serous chorioretinopathy–a randomized controlled prospective study

Roy Schwartz, Zohar Habot‐Wilner, Michael R. Martinez et al. · Acta Ophthalmologica · 2017 · 112 citations · Full text

An outbreak of carbapenem-resistant Acinetobacter baumannii in a COVID-19 dedicated hospital

Tamar Gottesman, Rina Fedorowsky, Rebecca Yerushalmi et al. · Infection Prevention in Practice · 2021 · 88 citations · Full text

A case-control study to identify predictors of 14-day mortality following carbapenem-resistant Acinetobacter baumannii bacteraemia

Amir Nutman, Rivka Glick, Elizabeth Temkin et al. · Clinical Microbiology and Infection · 2014 · 85 citations

Antimicrobial Susceptibility, Hospital Epidemiology, Infection Control +7